Clinical Cardiology Alert – March 1, 2003
March 1, 2003
View Issues
-
C-Reactive Protein Hits the Big Time
There has been a drum roll of reports over the past several years regarding high-sensitivity c-reactive protein (hs-CRP) in the evaluation of primary and secondary cardiovascular prevention. -
Coated Stents for In-Stent Restenosis
Synopsis: Sirolimus-eluting stents markedly reduce in-stent restenosis and clinical events over 1 year in patients with restenosis in conventional stents. -
Risk of Arrhythmic Events in Asymptomatic Patients with Wolff-Parkinson-White Pattern
Synopsis: In asymptomatic patients with preexcitation, electrophysiologic testing can stratify the risk of future symptomatic and fatal arrhythmic events. -
Cardioversion of Recent-Onset Atrial Fibrillation: Amiodarone vs Placebo and Class 1c Drugs
Synopsis: Amiodarone is superior to placebo for cardioversion of AF when measured at 24 hours after drug administration. -
The New Natural History of Marfan’s Syndrome
Synopsis: Death due to cardiac structural complications is rare in young Marfans patients followed carefully on medical therapy, but arrhythmogenic sudden death occurs and is more common in those with LV dilatation. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Smallpox Vaccination Guidelines Published by CDC
The Centers for Disease Control and Prevention published Smallpox Vaccination and Adverse ReactionsGuidance for Clinicians in the Jan. 24th edition of Morbidity and Mortality Weekly Report.